EBP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EBP Antibodies for investigating Emopamil-binding protein (EBP) functions. EBP Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Emopamil-binding protein plays a critical role in cholesterol biosynthesis and regulates steroidogenesis. EBP maintains cellular membrane integrity and influences key signaling pathways, making it a significant focus in metabolic disorder and neurodegenerative disease research. Scientists studying EBP can gain valuable insights into cholesterol metabolism and its impact on human health. Research focusing on EBP contributes to understanding various physiological processes and developing potential therapeutic strategies. Investigating EBP functions helps reveal its involvement in cellular homeostasis and disease progression. The monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cholesterol metabolism and its role in human health and disease.